Orphazyme
Orphazyme is a Denmark-based biopharmaceutical company that develops and commercializes therapies for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Orphazyme Information
Geographic Data
Address: Ole Maaloes Vej 3
City: Copenhagen
State: capital region
Zip: 2200
Country: DK
Financial Info
Stage:
post ipo equity
Raised Last:
$109M
Raised Total:$263M
Social
Metrics
4,164,552Website Global Rank
2,852Website Monthly Traffic
Twitter Followers
Description
Orphazyme is a Denmark-based biopharmaceutical company that develops and commercializes therapies for the treatment of neurodegenerative diseases.
Contact Phone:
Contact Email:
Orphazyme went public on 10/1/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/1/2020
IPO Valuation:
$381M
Ticker Symbol:
ORPH
IPO Price:
$11/share
Amount Raised:
$84M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
